Home > Healthcare > Medical Devices > Diagnostic Devices > U.S. Biological Sample Collection Kits Market

U.S. Biological Sample Collection Kits Market Share

Report ID: GMI10495
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

U.S. Biological Sample Collection Kits Market Companies

As the demand for accurate sample collection kits escalates, market expansion, collaboration, and investment in advanced solutions become crucial strategies for industry players.

Prominent players operating in the biological sample collection kits industry include:

Abbott Laboratories
Becton, Dickinson and Company
CTK Biotech, Inc.
F. Hoffmann-La Roche Ltd
Hardy Diagnostics
Laboratory Corporation of America Holdings
Lucence Health Inc.
Medline Industries, Inc.
Puritan Medical Products
QIAGEN
Thermo Fisher Scientific, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. biological sample collection kits industry was valued at USD 2.5 billion in 2023 and is expected to exhibit 7.8% CAGR from 2024 to 2032 due to rising usage of laboratory tests for precise disease diagnosis

The swabs product segment generated USD 695.2 million in 2023 as they are essential for collecting samples to diagnose various infectious diseases beyond COVID-19

U.S. biological sample collection kits market from the hospitals and clinics end-use segment is expected to grow at 7.6% CAGR between 2024 and 2032 as they perform a broad spectrum of diagnostic testing, including blood testing, urine testing, swab testing, and tissue biopsies

Abbott Laboratories, Becton, Dickinson and Company, CTK Biotech, Inc., F. Hoffmann-La Roche Ltd, Hardy Diagnostics, Laboratory Corporation of America Holdings, Lucence Health Inc., and Medline Industries, Inc.